In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides

Sakawrat Kanthawong1, Kamran Nazmi, Surasakdi Wongratanacheewin

  • 1Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.

Insights

Antimicrobial peptides show promise against drug-resistant Burkholderia pseudomallei. The human cathelicidin peptide LL-37 effectively killed all tested B. pseudomallei isolates, including antibiotic-resistant strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Burkholderia pseudomallei causes melioidosis, a severe infection with high mortality rates.
  • Intrinsic antibiotic resistance in B. pseudomallei necessitates novel therapeutic strategies.
  • Antimicrobial peptides (AMPs) offer broad-spectrum bactericidal activity and immunomodulatory effects.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of 10 AMPs against 24 B. pseudomallei isolates.
  • To identify potent AMPs effective against antibiotic-resistant strains of B. pseudomallei.
  • To investigate the influence of lipopolysaccharide (LPS) phenotype on bacterial susceptibility to AMPs.

Main Methods:

  • In vitro testing of 10 AMPs, including histatin 5, LL-37, and lactoferrin peptides, against 24 B. pseudomallei isolates.
  • Determination of peptide dose-dependency and bacterial isolate variability in antimicrobial activity.
  • Assessment of susceptibility across different LPS phenotypes (smooth type A, smooth type B, rough type).

Main Results:

  • Peptide efficacy varied with dose and bacterial isolate.
  • Human cathelicidin peptide LL-37 demonstrated the most potent killing activity.
  • B. pseudomallei with smooth type A LPS were more susceptible than those with type B or rough LPS.
  • LL-37 effectively inhibited B. pseudomallei isolates resistant to ceftazidime and trimethoprim/sulfamethoxazole.

Conclusions:

  • LL-37 exhibits broad-spectrum antimicrobial activity against B. pseudomallei, irrespective of LPS phenotype.
  • LL-37 is a promising therapeutic candidate for treating melioidosis, including infections caused by multidrug-resistant strains.
  • AMPs represent a viable alternative to conventional antibiotics for combating B. pseudomallei infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...